"Keratin-9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type II keratin found predominantly expressed in the terminally differentiated EPIDERMIS of palms and soles. Mutations in the gene for keratin 9 are associated with KERATODERMA, PALMOPLANTAR, EPIDERMOLYTIC.
| Descriptor ID |
D053534
|
| MeSH Number(s) |
D05.750.078.593.450.600.900 D12.776.220.475.450.600.900 D12.776.860.607.650.900
|
| Concept/Terms |
Keratin-9- Keratin-9
- Keratin 9
- Cytokeratin 9
- Cytokeratin-9
|
Below are MeSH descriptors whose meaning is more general than "Keratin-9".
Below are MeSH descriptors whose meaning is more specific than "Keratin-9".
This graph shows the total number of publications written about "Keratin-9" by people in this website by year, and whether "Keratin-9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Keratin-9" by people in Profiles.
-
Fu DJ, Thomson C, Lunny DP, Dopping-Hepenstal PJ, McGrath JA, Smith FJD, Irwin McLean WH, Leslie Pedrioli DM. Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. J Invest Dermatol. 2014 Mar; 134(3):754-763.
-
Leslie Pedrioli DM, Fu DJ, Gonzalez-Gonzalez E, Contag CH, Kaspar RL, Smith FJ, McLean WH. Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Invest Dermatol. 2012 Jun; 132(6):1627-35.